vs
Side-by-side financial comparison of Crexendo, Inc. (CXDO) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $18.1M, roughly 1.0× Crexendo, Inc.). Crexendo, Inc. runs the higher net margin — 6.7% vs -3.0%, a 9.8% gap on every dollar of revenue. On growth, Crexendo, Inc. posted the faster year-over-year revenue change (11.2% vs -25.6%). Over the past eight quarters, Crexendo, Inc.'s revenue compounded faster (12.4% CAGR vs -10.1%).
Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CXDO vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.1M | $18.3M |
| Net Profit | $1.2M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 6.3% | -2.2% |
| Net Margin | 6.7% | -3.0% |
| Revenue YoY | 11.2% | -25.6% |
| Net Profit YoY | 140.2% | 26.7% |
| EPS (diluted) | $0.03 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.1M | $18.3M | ||
| Q3 25 | $17.5M | $15.9M | ||
| Q2 25 | $16.6M | $16.1M | ||
| Q1 25 | $16.1M | $18.9M | ||
| Q4 24 | $16.2M | $24.7M | ||
| Q3 24 | $15.6M | $28.3M | ||
| Q2 24 | $14.7M | $25.8M | ||
| Q1 24 | $14.3M | $22.7M |
| Q4 25 | $1.2M | $-554.0K | ||
| Q3 25 | $1.4M | $-1.8M | ||
| Q2 25 | $1.2M | $-1.5M | ||
| Q1 25 | $1.2M | $-1.5M | ||
| Q4 24 | $507.0K | $-756.0K | ||
| Q3 24 | $148.0K | $1.7M | ||
| Q2 24 | $588.0K | $343.0K | ||
| Q1 24 | $434.0K | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 6.3% | -2.2% | ||
| Q3 25 | 7.5% | -9.9% | ||
| Q2 25 | 6.7% | -8.4% | ||
| Q1 25 | 7.2% | -7.2% | ||
| Q4 24 | 3.9% | -2.1% | ||
| Q3 24 | 0.9% | 6.8% | ||
| Q2 24 | 3.9% | 2.0% | ||
| Q1 24 | 3.4% | -5.8% |
| Q4 25 | 6.7% | -3.0% | ||
| Q3 25 | 8.3% | -11.0% | ||
| Q2 25 | 7.4% | -9.3% | ||
| Q1 25 | 7.3% | -8.0% | ||
| Q4 24 | 3.1% | -3.1% | ||
| Q3 24 | 0.9% | 5.9% | ||
| Q2 24 | 4.0% | 1.3% | ||
| Q1 24 | 3.0% | -7.6% |
| Q4 25 | $0.03 | $-0.01 | ||
| Q3 25 | $0.05 | $-0.05 | ||
| Q2 25 | $0.04 | $-0.05 | ||
| Q1 25 | $0.04 | $-0.04 | ||
| Q4 24 | $0.03 | $-0.02 | ||
| Q3 24 | $0.00 | $0.04 | ||
| Q2 24 | $0.02 | $0.01 | ||
| Q1 24 | $0.01 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.7M |
| Total DebtLower is stronger | $114.0K | — |
| Stockholders' EquityBook value | $63.8M | $37.0M |
| Total Assets | $77.7M | $57.1M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | $114.0K | — | ||
| Q3 25 | $236.0K | — | ||
| Q2 25 | $356.0K | — | ||
| Q1 25 | $475.0K | — | ||
| Q4 24 | $592.0K | — | ||
| Q3 24 | $709.0K | — | ||
| Q2 24 | $823.0K | — | ||
| Q1 24 | $937.0K | — |
| Q4 25 | $63.8M | $37.0M | ||
| Q3 25 | $61.3M | $37.0M | ||
| Q2 25 | $58.3M | $30.4M | ||
| Q1 25 | $55.2M | $31.5M | ||
| Q4 24 | $51.4M | $32.6M | ||
| Q3 24 | $49.5M | $29.1M | ||
| Q2 24 | $48.2M | $23.5M | ||
| Q1 24 | $46.8M | $20.6M |
| Q4 25 | $77.7M | $57.1M | ||
| Q3 25 | $76.0M | $57.5M | ||
| Q2 25 | $71.4M | $52.6M | ||
| Q1 25 | $67.4M | $54.0M | ||
| Q4 24 | $64.9M | $59.2M | ||
| Q3 24 | $62.3M | $57.1M | ||
| Q2 24 | $59.6M | $53.0M | ||
| Q1 24 | $57.5M | $50.7M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.5% |
| Cash ConversionOCF / Net Profit | 1.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $2.3M | ||
| Q3 25 | $4.4M | $-1.3M | ||
| Q2 25 | $1.3M | $1.8M | ||
| Q1 25 | $1.2M | $-3.5M | ||
| Q4 24 | $2.2M | $865.0K | ||
| Q3 24 | $1.6M | $4.3M | ||
| Q2 24 | $2.7M | $1.4M | ||
| Q1 24 | $-166.0K | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | $1.3M | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $2.1M | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | 7.7% | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | 13.2% | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | 0.1% | 1.0% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.2% | 1.6% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.0% | 0.6% |
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.05× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | 10.95× | 2.57× | ||
| Q2 24 | 4.51× | 4.20× | ||
| Q1 24 | -0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CXDO
| Services | $8.6M | 48% |
| Software Solution Segment | $8.3M | 46% |
| Products | $1.1M | 6% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
